**Chapter 3**

*Pheochromocytoma, Paraganglioma and Neuroblastoma*

Long-term prognosis of patients with pediatric pheochromocytoma. Endocr

Relat Cancer. 2014;21(1):17-25.

tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma. Surg (United States). 2017;161(1):230-239.

[48] Mishra A, Mehrotra PK, Agarwal G, Agarwal A, Mishra SK. Pediatric and adolescent pheochromocytoma: Clinical presentation and outcome of surgery. Indian Pediatr. 2014;51(4):299-302.

[47] Cascón A, Inglada-Pérez L, Comino-Méndez I, De Cubas AA, Letón R, Mora J, et al. Genetics of pheochromocytoma and paraganglioma in Spanish pediatric patients. Endocr

Relat Cancer. 2013;20(3).

[49] Makri A, Akshintala S, Derse-Anthony C, Del Rivero J, Widemann B, Stratakis CA, et al. Pheochromocytoma in Children and Adolescents with Multiple Endocrine Neoplasia Type 2B. J Clin Endocrinol

Metab. 2020;104(1):7-12.

[50] Sarathi V. Characteristics of Pediatric Pheochromocytoma/ paraganglioma. 2020;21(3):470-4.

[51] Tibbetts MD, Wise R, Forbes B, Hedrick HL, Levin A V. Hypertensive retinopathy in a child caused by pheochromocytoma: Identification after a failed school vision screening. J AAPOS [Internet]. 2012;16(1):97- 9. Available from: http://dx.doi. org/10.1016/j.jaapos.2011.09.010

[52] de Tersant M, Généré L, Freyçon C, Villebasse S, Abbas R, Barlier A, et al. Pheochromocytoma and Paraganglioma in Children and Adolescents: Experience of the French Society of Pediatric Oncology (SFCE). J Endocr Soc.

[53] Ross JH. Pheochromocytoma: Special considerations in children. Urol Clin North Am. 2000;27(3):393-402.

[54] Bausch B, Wellner U, Bausch D, Schiavi F, Barontini M, Sanso G, et al.

**24**

2020;4(5):1-12.
